CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- 4 Grant or award Director acquired 13,000 shares (grant or award)
- 4 Grant or award Director acquired 13,000 shares (grant or award)
- 4 Grant or award Director acquired 13,000 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Grant or award See Remarks acquired 150,000 shares (grant or award)
- 4 Shares withheld for taxes See Remarks gave up 9,948 shares (to pay taxes)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 20,000 shares at $4.90 ($98,000)
- 4 Open-market buy See Remarks bought 50,000 shares at $4.90 ($245,000)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 6 of 20 · 383 filings